HCV programs and perspectives

Eliminating hepatitis C will mean uniting all of us behind a collective effort to overcome the obstacles. The estimated 300 micro-elimination projects that AbbVie supports are forging partnerships that help concentrate our efforts, share learnings and scale what works. These are just a few of our efforts to date:

AbbVie Australia

No C in Blacktown

An Australian project is replicating a successful model of diabetes screening and treatment at Blacktown Hospital in Western Sydney to improve HCV awareness among at risk groups including people who inject drugs.

AbbVie Austria

STD and HCV Awareness

In Austria, a project aiming to increase HCV awareness and screenings is in development, seeking to identify undiagnosed and untreated patients in an effort to increase the diagnosis and treatment rates among men who have sex with men.

AbbVie Estonia

From Micro to Macro

In Estonia, a protocol is being developed to test, treat and follow up with adult hospital patients with elevated liver enzymes who are at risk for hepatitis C infection. Today, these patients are undiagnosed due to the lack of funding for screening.

AbbVie France

RECONVOC

In France, a project is being developed to locate patients who have fallen off the HCV treatment pathway after moving and changing addresses. This project will help link these patients back to care and the HCV treatment pathway.

AbbVie Germany

Project Plus

In Germany, a new referral network called Project Plus has been set up at addiction treatment centers. The network is helping people who inject drugs battle addiction and other challenges they face, enabling them to prioritize hepatitis C care.

See the story

AbbVie Israel

Road to the Cure

In Israel, an effort to map the most frequented locations of people who inject drugs is helping healthcare providers bring laboratory services and hepatitis C treatment to places where these patients feel comfortable.

AbbVie Italy

HAND: Hepatitis Addiction Recovery Network

This AbbVie-sponsored project in Italy is working to educate people who use drugs about hepatitis C including screenings and early diagnosis, as well as improve the linkage to care and treatment rate through educational activities. 

AbbVie Japan

Arcadia Hiroshima

In Japan, a partnership between local and regional governments is helping to improve hepatitis C awareness among general practitioners and non-specialists to support the HCV referral system and link more patients to care.

AbbVie Mexico

C-onectando Vidas: Hemodialysis IMSS Delegación Oriente

In the IMSS Regional State of Eastern Mexico, a project is determining how effective systematically implementing the ‘5 Steps to Micro-elimination Model’ is to eliminate hepatitis C in dialysis clinics.

AbbVie Portugal

One Step More

In Portugal, a former inmate has created a peer-to-peer counseling program, One Step More, that goes inside prison walls to motivate people to seek hepatitis C care.

See the story

AbbVie Romania

Hep C A-L-E-R-T

A project in Romania is working to show that hepatitis C elimination is possible through cost-effective, point-of-care testing using a rapid finger stick test in regional hospitals.

AbbVie Russia

HCV Free Childhood

A new project in Russia, HCV Free Childhood, is developing a roadmap to maximize adolescent screening, referral and treatment for hepatitis C.

AbbVie South Korea

HCV Free Gurye

In a remote South Korean mountain town, physicians and medical education experts are raising awareness of hepatitis C and testing adults aged 40-79, a high-risk age group.

AbbVie Spain

Hospital Clinic of Barcelona

A project in Spain is helping to facilitate hepatitis C patient referrals from general practitioners to specialists, and build a referral network at harm reduction centers to help people who inject drugs.

AbbVie Switzerland

HepCare

A project in Switzerland is working to increase the involvement of general practitioners in the testing, treatment and diagnosis of hepatitis C to close gaps in the treatment cascade.

AbbVie Switzerland

Peer Motivation

People who inject drugs (PWIDs) are the largest identifiable high-risk population for HCV in Switzerland. A project here seeks to establish testing at drug treatment centers and launch peer programs to motivate PWIDs to seek screenings and care.

Hepatitis C elimination in the US

HCV experts are also working to eliminate the disease in the United States. We are highlighting what HCV micro-elimination looks like in the U.S. to showcase the learnings, the challenges and the successes in the relentless pursuit to eliminate hepatitis C.* 

Maryland

Telehealth in Appalachia*

In western Maryland, a university-based project has established a telehealth clinic here to improve care.

* AbbVie is not directly affiliated with these efforts.